《Nature,3月17日,Coronavirus: three things all governments and their science advisers must do now》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-18
  • “Some of the most important choices about a nation’s physical health are made, or not made, by a handful of men, in secret.”

    Sixty-odd years ago, the chemist, writer and civil servant Charles Percy Snow revealed in his book Science and Government the shocking extent to which science advice to governments during the Second World War had lacked evidence. As the world stands on the precipice of one of the worst infectious-disease outbreaks in a century, his observations are just as relevant today.

  • 原文来源:https://www.nature.com/articles/d41586-020-00772-4
相关报告
  • 《Science,2月28日,The United States badly bungled coronavirus testing—but things may soon improve》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-29
    • Speed is critical in the response to COVID-19. So why has the United States been so slow in its attempt to develop reliable diagnostic tests and use them widely? The World Health Organization (WHO) has shipped testing kits to 57 countries. China had five commercial tests on the market 1 month ago and can now do up to 1.6 million tests a week; South Korea has tested 65,000 people so far. The U. S. Centers for Disease Control and Prevention (CDC), in contrast, has done only 459 tests since the epidemic began. The rollout of a CDC-designed test kit to state and local labs has become a fiasco because it contained a faulty reagent. Labs around the country eager to test more suspected cases—and test them faster—have been unable to do so. No commercial or state labs have the approval to use their own tests.
  • 《Science,3月11日,New coronavirus outbreak: Framing questions for pandemic prevention》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-12
    • New coronavirus outbreak: Framing questions for pandemic prevention Scott P. Layne, James M. Hyman, David M. Morens and Jeffery K. Taubenberger* See all authors and affiliations Science Translational Medicine 11 Mar 2020: Vol. 12, Issue 534, eabb1469 DOI: 10.1126/scitranslmed.abb1469 Abstract We need to understand and quantify the dominant variables that govern the SARS–CoV-2 outbreak, rather than relying exclusively on confirmed cases and their geospatial spread.